Table 2.

MicroRNA over-expressed in sets of pooled plasma from patients with pancreatic cancer compared to those from healthy controls.

	Fold-change (95% CI)	P-value
miR-4666a-3p	1.28 (1.20–1.38)	<0.001
miR-1273g-3p	5.09 (3.08–8.42)	<0.001
let-7b-5p	1.64 (1.35–1.99)	<0.001
miR-122-5p	5.20 (2.68–10.11)	0.001
miR-6126	3.52 (2.09–5.93)	0.001
miR-1912	1.35 (1.19–1.53)	0.001
miR-3197	7.47 (3.20–17.45)	0,001
miR-4793-3p	7.91 (3.16–19.90)	0,001
miR-7107-5p	3.77 (2.08–6.85)	0.001
miR-1246	6.75 (2.67–17.10)	0.002
mir-4754	1.13 (1.06–1.20)	0.002
miR-4750-5p	1.25 (1.12–1.41)	0.002
miR-18a-5p	1.89 (1.36–2.62)	0.003
miR-619-5p	1.68 (1.28–2.21)	0.003
miR-4734	2.48 (1.54–4.00)	0.003
mir-6840	1.23 (1.10–1.38)	0.003
miR-1587	2.03 (1.40–2,96)	0.003
mir-487a	1.30 (1.13–1.51)	0.003
miR-4674	3.20 (1.70–6.04)	0.003
miR-193a-5p	5.17 (2.12–12.64)	0.003
miR-1275	2.13 (1.40–3.24)	0.004
miR-3195	1.79 (1.26–2.47)	0.004
miR-7108-5p	1.67 (1.25–2.22)	0.004
miR-548aq-5p	1.34 (1.14–1.59)	0.004
mir-4278	1.90 (1.04–1.14)	0.004
mir-2392	1.22 (1.09–1.38)	0.005
miR-324-3p	1.71 (1–34)	0.005
miR-7150	2.02 (1.34–3.04)	0.005
miR-4423-3p	1.23 (1.09–1.39)	0.005
miR-4717-3p	1.94 (1.31–2.87)	0.005
miR-4661-3p	1.26 (1.10–1.45)	0.005
miR-652-3p	2.96 (1.56–5.63)	0.005
miR-6855-3p	1.24 (1.09–1.41)	0.005
miR-1268b	1.72 (1.24–2.39)	0.006
miR-3152-5p	1.15 (1.06–1.25)	0.006
miR-6722-3p	1.82 (1.26–2.63)	0.006
mir-4674	1.26 (1.09–1.45)	0.007
miR-4486	2.40 (1.39–4.17)	0.007
miR-3162-5p	1.42 (1.14–1.77)	0.007
miR-4701-3p	1.91 (1.27–2.88)	0.007
miR-5093	1.88 (1.26–2.81)	0.007
miR-4507	2.20 (1.34–3.61)	0.007
miR-378a-3p	2.08 (1.31–3.30)	0.007
miR-223-3p	2.02 (1.29–3.15)	0.007
miR-5001-5p	1.77 (1.23-2.55)	0.007
miR-1301-3p	2.01 (1.29-3.14)	0.008
miR-4498	1.52 (1.15-1.99)	0.009
miR-4487	1.29 (1.09-1.53)	0.009
miR-4524b-3p	1.29 (1.09-1.53)	0.009
miR-6090	1.56 (1.16-2.10)	0.010
miR-3654	1.21 (1.06-1.38)	0.010